Robert A. Schnoll

Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial

Caryn Lerman, Robert A. Schnoll, Paul M. Cinciripini et al. · The Lancet Respiratory Medicine · 2015 · 299 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study

Robert A. Schnoll, Freda Patterson, E. Paul Wileyto et al. · Pharmacology Biochemistry and Behavior · 2008 · 211 citations · Full text

Public Health, Pharmacokinetics, Pharmacology +14

Correlates of tobacco use among smokers and recent quitters diagnosed with cancer

Robert A. Schnoll, Michael Malstrom, Calvin James et al. · Patient Education and Counseling · 2002 · 163 citations

Public Health, Oncology, Cancer Control +13

Brief Physician-Initiated Quit-Smoking Strategies for Clinical Oncology Settings: A Trial Coordinated by the Eastern Cooperative Oncology Group

Robert A. Schnoll, Bin Zhang, Montserrat Rué et al. · Journal of Clinical Oncology · 2003 · 140 citations

Public Health, Health Behavior, Oncology +17

A structural model of the relationships among stage of disease, age, coping, and psychological adjustment in women with breast cancer

Robert A. Schnoll, Lisa L. Harlow, Leo L. Stolbach et al. · Psycho-Oncology · 1998 · 133 citations · Full text

Medicine, Oncology, Psychology +11